Company: PSTV
Filing Date: 2025-06-20
Form Type: 8-K
Source: 0001193125-25-143665
Chunk: 0

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-06-20
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01.      Entry into Material Definitive Agreement.  

On June 17, 2025, Plus Therapeutics, Inc. (the “ Company”) entered into a purchase agreement (the “ Purchase Agreement”) and a registration rights agreement (the “ Registration Rights Agreement”) with Lincoln Park Capital Fund, LLC (“ Lincoln Park”), pursuant to which Lincoln Park has committed to purchase up to $50 million of the Company’s common stock, $0.001 par value per share.

Under the terms and subject to the conditions of the Purchase Agreement, the Company has the right, but not the obligation, to sell to Lincoln Park, and Lincoln Park is obligated to purchase up to $50.0 million of the Company’s common stock (the “ Commitment Amount”). Such sales of common stock by the Company, if any, will be subject to certain limitations, and may occur from time to time, at the Company’s sole discretion, over the36-monthperiod commencing on the date that a registration statement covering the resale of shares of common stock that have been and may be issued under the Purchase Agreement, which the Company initially filed on June 18, 2025 with the Securities and Exchange Commission (the “ SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC and a final prospectus in connection therewith is filed and the other conditions set forth in the Purchase Agreement are satisfied.

Under the Purchase Agreement, so long as the closing sale price of the Company’s common stock is not below $0.10 on a particular business day, the Company may from time to time direct Lincoln Park to purchase up to 300,000 shares of common stock in a regular purchase (the “ Regular Purchase”) on such business day (such share amount limitation, the “ Regular Purchase Share Limit”), provided, however, that the Regular Purchase may be increased to up to 400,000 shares if the last closing sale price for the common stock at the time of the sale is not below $0.50 and up to a maximum amount of 500,000 shares of the Company’s common stock if the last closing sale price for the common stock at the time of sale is not below $0.75. In each case, Lincoln Park’s maximum commitment in any single Regular Purchase may not exceed $1,000,000. The Regular Purchase Share Limit is subject to proportionate adjustment in the event of a reorganization, recapitalization, non-cashdividend, stock split or other similar transaction; provided, that